title: Adenosine inhibits renin release from juxtaglomerular cells via an A1 receptor-TRPC-mediated pathway.
abstract: Renin is synthesized and released from juxtaglomerular (JG) cells. Adenosine inhibits renin release via an adenosine A1 receptor (A1R) calcium-mediated pathway. How this occurs is unknown. In cardiomyocytes, adenosine increases intracellular calcium via transient receptor potential canonical (TRPC) channels. We hypothesized that adenosine inhibits renin release via A1R activation, opening TRPC channels. However, higher concentrations of adenosine may stimulate renin release through A2R activation. Using primary cultures of isolated mouse JG cells, immunolabeling demonstrated renin and A1R in JG cells, but not A2R subtypes, although RT-PCR indicated the presence of mRNA of both A2AR and A2BR. Incubating JG cells with increasing concentrations of adenosine decreased renin release. Different concentrations of the adenosine receptor agonist N-ethylcarboxamide adenosine (NECA) did not change renin. Activating A1R with 0.5 μM N6-cyclohexyladenosine (CHA) decreased basal renin release from 0.22 ± 0.05 to 0.14 ± 0.03 μg of angiotensin I generated per milliliter of sample per hour of incubation (AngI/ml/mg prot) (P < 0.03), and higher concentrations also inhibited renin. Reducing extracellular calcium with EGTA increased renin release (0.35 ± 0.08 μg AngI/ml/mg prot; P < 0.01), and blocked renin inhibition by CHA (0.28 ± 0.06 μg AngI/ml/mg prot; P < 0. 005 vs. CHA alone). The intracellular calcium chelator BAPTA-AM increased renin release by 55%, and blocked the inhibitory effect of CHA. Repeating these experiments in JG cells from A1R knockout mice using CHA or NECA demonstrated no effect on renin release. However, RT-PCR showed mRNA from TRPC isoforms 3 and 6 in isolated JG cells. Adding the TRPC blocker SKF-96365 reversed CHA-mediated inhibition of renin release. Thus A1R activation results in a calcium-dependent inhibition of renin release via TRPC-mediated calcium entry, but A2 receptors do not regulate renin release.
authors.affiliation: Henry Ford Hospital, Dept. of Medicine, Hypertension and Vascular Research Division, 7088 E&R Bldg., 2799 W. Grand Blvd., Detroit, MI 48202. wbeierw1@hfhs.org.
authors.forename: M Cecilia
authors.initials: MC
authors.lastname: Ortiz-Capisano
authors.forename: Douglas K
authors.initials: DK
authors.lastname: Atchison
authors.forename: Pamela
authors.initials: P
authors.lastname: Harding
authors.forename: Robert D
authors.initials: RD
authors.lastname: Lasley
authors.forename: William H
authors.initials: WH
authors.lastname: Beierwaltes
mesh_terms: D000241:Adenosine / Q000502:physiology*; D000804:Angiotensin II / Q000502:physiology*; D000818:Animals; D005260:Female; D007606:Juxtaglomerular Apparatus / Q000378:metabolism*; D007678:Kidney Glomerulus / Q000166:cytology / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D043682:Receptor, Adenosine A1 / Q000502:physiology*; D012083:Renin / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*; D050051:Transient Receptor Potential Channels / Q000502:physiology*; D000092502:Renin Inhibitors
chemical_list: D000241:Adenosine; D000804:Angiotensin II; D043682:Receptor, Adenosine A1; D012083:Renin; D050051:Transient Receptor Potential Channels; D000092502:Renin Inhibitors
keywords: A1R; CHA; adenosine; adenosine receptors; calcium; renin; transient receptor potential canonical